Academic Content and Language Evaluation of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (4047)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
Mar 26, 2022 (publication date) through Nov 8, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Clinical Cases
ISSN
2307-8960
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Wang LN, Huang KJ, Wang L, Cheng HY. Overexpression of Ubiquilin4 is associated with poor prognosis in patients with cervical cancer. World J Clin Cases 2022; 10(9): 2783-2791 [PMID: 35434088 DOI: 10.12998/wjcc.v10.i9.2783] |
|---|---|
| URL: | https://www.wjgnet.com/2307-8960/full/v10/i9/2783.htm |
| Number | Citing Articles |
| 1 |
Quan Jiang, Hao Chen, Shixin Zhou, Tao Zhu, Wenshuai Liu, Hao Wu, Yong Zhang, Fenglin Liu, Yihong Sun. Ubiquilin-4 induces immune escape in gastric cancer by activating the notch signaling pathway. Cellular Oncology 2023; doi: 10.1007/s13402-023-00869-8
|
| 2 |
Li He, Heng Chen, Bin Ruan, Li He, Ming Luo, Yulun Fu, Rui Zou. UBQLN4 promotes the proliferation and invasion of non-small cell lung cancer cell by regulating PI3K/AKT pathway. Journal of Cancer Research and Clinical Oncology 2024; 150(7) doi: 10.1007/s00432-024-05862-8
|